Dr. Dhanabalan is a highly respected physician trained in Family Medicine and Occupational & Environmental Medicine, with specialization in heavy metals. She is a Fellow of the American Academy of Family Physicians, a Cannabinoid Medicine Specialist, and Medical Review Officer.
She completed her Bachelor of Arts degree with high honors from Rutgers University and her Medical degree from the University of Medicine & Dentistry in Newark, New Jersey. Dr. Dhanabalan completed a Family Practice Residency at the Medical University of South Carolina, in Charleston, South Carolina and then her Master of Public Health and Occupational & Environmental Medicine Residency and Fellowship at the Harvard School of Public Health in Boston, Massachusetts. She is also Certified by the American Academy of Cannabinoid Medicine and by the Medical Review Officer Certification Council.
She has received awards from the American College of Occupational & Environmental Medicine for her research project “Occupational & Environmental Exposure to Lead in South Indi”, and from the 7th World Ayurveda Conference & Arogya Expo for her presentation “Cannabis & The Therapeutic Uses”. She also received the Educational Achievement Award presented by Clover Leaf at Cannabis Business Awards 2017
She is the Founder/CEO for Global Health & Hygiene Solutions, LLC, established in 2006, with a mission to promote wellness and prevent illness. She worked for Kimberly Clark as Regional Medical Director for Asia Pacific, as well as for the Hanford Site in Richland, Washington, with the largest and most complex cleanup projects in the world, where plutonium was manufactured for the first nuclear bomb detonated in Japan.
She created the TotalHealthCareTHC model where she “Educates Embraces Empowers” patients and promotes cannabis as a treatment option at Uplifting Health and Wellness, in Natick, Massachusetts. She is an advocate, activist and educator and speaks globally about cannabis as a plant medicine. Her mission is to change the Stigma regarding Cannabis and for the world to know about the Endocannabinoid system through education
Dr. Dhanabalan believes “cannabis must be a first-line integrative treatment for cancer, not a last resort”. Furthermore, she advocates that patients involved in other promising clinical trials should be allowed to use cannabis if desired, and not be automatically excluded from such trials as they currently are.